Literature DB >> 32231346

Immune and TRG repertoire signature of the thymus in Down syndrome patients.

Shira Rabinowicz1,2, Atar Lev3, Yu Nee Lee3, Diti Machnes-Maayan3,4, Uriel Katz4,5, Amir Vardi4,6, David Mishali4,7, Raz Somech3,4.   

Abstract

BACKGROUND: Patients with Down syndrome (DS) are at increased risk for infections and autoimmune disorders. Although several immunological abnormalities were previously found, differences in T cell receptor repertoire have never been shown. Thus we compared the T cell receptor gamma (TRG) repertoire in DS and non-syndromic pediatric patients by next-generation sequencing, in addition to other immunological markers.
METHODS: Genomic DNA was extracted from thymuses of pediatric patients who underwent heart surgery, where six were with DS and six were non-syndromic patients. Peripheral blood counts, T cell subpopulations, thymus TCR excision circles (TRECs), spectratyping, and next-generation sequencing for TRG were analyzed.
RESULTS: The mean age of the patients was 7 months and the mean lymphocyte count was slightly lower in patients with DS, whereas thymus TREC results were similar to non-syndromic patients (p = 0.197). The TRG repertoire analysis showed that patients with DS had a significantly larger number of unique TRG sequences, together with decreased clonal expansion. Lastly, the V and J gene usages in the thymus were similar in DS and non-syndromic patients.
CONCLUSIONS: Patients with DS showed increased TRG repertoire diversity with decreased clonal expansion compared to non-syndromic patients. IMPACT: Alterations in T cell receptor gamma repertoire were found in patients with Down syndrome using next-generation sequencing (NGS) technique. Patients showed increased repertoire diversity and decreased clonal expansion compared to controls. These findings add to previous reports on abnormalities of other immune system components in patients with Down syndrome. NGS technique may point out differences not seen by previous methods. Repertoire abnormalities may contribute to those patients' predisposition to infections and autoimmune diseases.

Entities:  

Year:  2020        PMID: 32231346     DOI: 10.1038/s41390-020-0857-y

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

Review 1.  Immunology of Down syndrome: a review.

Authors:  A G Ugazio; R Maccario; L D Notarangelo; G R Burgio
Journal:  Am J Med Genet Suppl       Date:  1990

2.  Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21).

Authors:  R Philip; A C Berger; N H McManus; N H Warner; M A Peacock; L B Epstein
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

Review 3.  Immunological features of Down's syndrome: a review.

Authors:  L Nespoli; G R Burgio; A G Ugazio; R Maccario
Journal:  J Intellect Disabil Res       Date:  1993-12

4.  Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with wiskott-Aldrich syndrome.

Authors:  Amy E O'Connell; Stefano Volpi; Kerry Dobbs; Claudia Fiorini; Erdyni Tsitsikov; Helen de Boer; Isil B Barlan; Jenny M Despotovic; Francisco J Espinosa-Rosales; I Celine Hanson; Maria G Kanariou; Roxana Martínez-Beckerat; Alvaro Mayorga-Sirera; Carmen Mejia-Carvajal; Nesrine Radwan; Aaron R Weiss; Sung-Yun Pai; Yu Nee Lee; Luigi D Notarangelo
Journal:  Front Immunol       Date:  2014-07-18       Impact factor: 7.561

  4 in total
  1 in total

Review 1.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.